The efficacy of maintenance therapy after remission induction with tacrolimus in ulcerative colitis with and without previous tumor necrosis factor‐α inhibitor

BACKGROUND AND AIM: Tacrolimus (TAC) is an important therapeutic option for remission induction in patients with refractory ulcerative colitis (UC). However, there is little evidence available on long‐term outcomes and maintenance treatments after TAC therapy, especially in cases with previous tumor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JGH Open
Main Authors: Suzuki, Taketo, Mizoshita, Tsutomu, Tanida, Satoshi, Sugimura, Naomi, Katano, Takahito, Nishie, Hirotada, Kataoka, Hiromi
Formato: Artigo
Idioma:Inglês
Publicado em: Wiley Publishing Asia Pty Ltd 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6586576/
https://ncbi.nlm.nih.gov/pubmed/31276039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgh3.12140
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados